Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2019-11-29 01:30Underwater telecom cables make superb seismic network and more...
2019-11-28 01:30New center illuminates ‘microscopic universe within each cell’ and more...
2019-11-27 01:30Cortexyme to Present at the Evercore ISI 2nd Annual HealthCONx Conference on December 3, 2019 and more...
2019-11-26 01:30Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule and more...
2019-11-23 01:30Google-linked fund seeds Berkeley medical AI startup and more...
2019-11-22 01:30BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A and more...
2019-11-21 01:30Gilead CEO Daniel O’Day says company is in an ‘acquisitive mode’ and more...
2019-11-20 01:30Myovant to Seek FDA OK on Pill to Treat Advanced Prostate Cancer and more...
2019-11-19 01:30New Kaiser Permanente medical school to be named after Bernard Tyson and more...
2019-11-18 01:30Personalis, Inc. to Present New Data at the AACR Tumor Immunology and Immunotherapy Conference and more...
2019-11-16 01:30Maxar Technologies Announces Pricing of $1.0 Billion Senior Secured Notes Offering and more...
2019-11-15 01:30Stanford doctoral student named IF/THEN ambassador and more...
2019-11-14 01:30Through Apple Heart Study, Stanford Medicine Researchers Show Wearable Technology Can Help Detect Atrial Fibrillation and more...
2019-11-13 01:30NTT Research and Technical University of Munich (TUM) Enter Joint Research Agreement to Collaborate on Technologies to Affect the Future of Patient Care and more...
2019-11-12 01:30This simple acquisition shows how genetic testing is consolidating, cozying up to doctors and patients and more...
2019-11-10 01:30Aduro Biotech Announces Presentation of Results from First-in-Human Phase 1 Study of Anti-CD27 Agonist as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 34th ...
2019-11-09 01:30AgeX Therapeutics to Present at Investing in the Age of Longevity Conference and more...
2019-11-08 01:30Introductory seminar shoots for the stars and more...
2019-11-07 01:30NTT Research Partners with Simons Institute at UC Berkeley and more...
2019-11-06 01:30DNA Script to Open U.S. Office in South San Francisco to Support Commercialization of the Company’s Industry-Leading Enzymatic Synthesis Technology and more...
2019-11-05 01:30Maxar Technologies Reports Third Quarter 2019 Results and more...
2019-11-02 01:30Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) and more...
2019-11-01 01:30Foresite Labs Launches to Incubate Transformative Companies in Data Science and Healthcare and more...

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語